{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T14:42:19Z","timestamp":1791384139384,"version":"4.3.3"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,5,6]],"date-time":"2015-05-06T00:00:00Z","timestamp":1430870400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.jneuroim.2015.04.006","type":"journal-article","created":{"date-parts":[[2015,4,25]],"date-time":"2015-04-25T12:47:52Z","timestamp":1429966072000},"page":"74-85","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":167,"special_numbering":"C","title":["DMF, but not other fumarates, inhibits NF-\u03baB activity in vitro in an Nrf2-independent manner"],"prefix":"10.1016","volume":"283","author":[{"given":"Geoffrey O.","family":"Gillard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Collette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert H.","family":"Scannevin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Huss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason D.","family":"Fontenot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2015.04.006_bb0005","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/1742-2094-9-163","article-title":"Effects of dimethyl fumarate on neuroprotection and immunomodulation","volume":"9","author":"Albrecht","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2015.04.006_bb0010","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.vascn.2005.06.003","article-title":"Characterization of compound mechanisms and secondary activities by BioMAP analysis","volume":"53","author":"Berg","year":"2006","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.jneuroim.2015.04.006_bb0015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.vascn.2009.10.001","article-title":"Chemical target and pathway toxicity mechanisms defined in primary human cell systems","volume":"61","author":"Berg","year":"2010","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.jneuroim.2015.04.006_bb0020","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1172\/JCI72151","article-title":"Hydroxycarboxylic acid receptor 2 mediates dimethyl fumarate's protective effect in EAE","volume":"124","author":"Chen","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2015.04.006_bb0025","doi-asserted-by":"crossref","first-page":"5015","DOI":"10.4049\/jimmunol.1101868","article-title":"Dimethyl fumarate, an immune modulator and inducer of the antioxidant response, suppresses HIV replication and macrophage-mediated neurotoxicity: a novel candidate for HIV neuroprotection","volume":"187","author":"Cross","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2015.04.006_bb0030","doi-asserted-by":"crossref","first-page":"15244","DOI":"10.1074\/jbc.M113.540633","article-title":"Transcription factors NRF2 and NF-kappaB are coordinated effectors of the Rho family, GTP-binding protein RAC1 during inflammation","volume":"289","author":"Cuadrado","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jneuroim.2015.04.006_bb0035","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00403-013-1332-y","article-title":"Detection of fumarate\u2013glutathione adducts in the portal vein blood of rats: evidence for rapid dimethylfumarate metabolism","volume":"305","author":"Dibbert","year":"2013","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.jneuroim.2015.04.006_bb0040","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1161\/ATVBAHA.111.241836","article-title":"Anti-inflammatory effects of nicotinic acid in human monocytes are mediated by GPR109A dependent mechanisms","volume":"32","author":"Digby","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.jneuroim.2015.04.006_bb0045","first-page":"7","article-title":"The New England Journal of Medicine publishes pivotal data demonstrating efficacy and safety of oral BG-12 (dimethyl fumarate) in multiple sclerosis","volume":"34","author":"Fox","year":"2012","journal-title":"Can. J. Neurosci. Nurs."},{"issue":"12","key":"10.1016\/j.jneuroim.2015.04.006_bb0365","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1056\/NEJMoa1206328","article-title":"CONFIRM Study Investigators, Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis","volume":"367","author":"Fox","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2015.04.006_bb0050","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1185\/03007995.2013.849236","article-title":"BG-12 (dimethyl fumarate): a review of mechanism of action, efficacy, and safety","volume":"30","author":"Fox","year":"2014","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.jneuroim.2015.04.006_bb0055","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.lfs.2004.01.024","article-title":"Role of cysteine residues of p65\/NF-kappaB on the inhibition by the sesquiterpene lactone parthenolide and N-ethyl maleimide, and on its transactivating potential","volume":"75","author":"Garcia-Pineres","year":"2004","journal-title":"Life Sci."},{"key":"10.1016\/j.jneuroim.2015.04.006_bb0060","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/j.1365-2133.2007.07779.x","article-title":"Dimethylfumarate inhibits nuclear binding of nuclear factor kappaB but not of nuclear factor of activated T cells and CCAAT\/enhancer binding protein beta in activated human T cells","volume":"156","author":"Gerdes","year":"2007","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jneuroim.2015.04.006_bb0065","doi-asserted-by":"crossref","first-page":"C791","DOI":"10.1152\/ajpcell.00014.2010","article-title":"Targeting glutathione by dimethylfumarate protects against experimental malaria by enhancing erythrocyte cell membrane scrambling","volume":"299","author":"Ghashghaeinia","year":"2010","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.jneuroim.2015.04.006_bb0070","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1084\/jem.20100977","article-title":"Fumarates improve psoriasis and multiple sclerosis by inducing type II dendritic cells","volume":"208","author":"Ghoreschi","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2015.04.006_bb0075","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2165\/11539820-000000000-00000","article-title":"Oral therapies for multiple sclerosis: a review of agents in phase III development or recently approved","volume":"25","author":"Gold","year":"2011","journal-title":"CNS Drugs"},{"issue":"12","key":"10.1016\/j.jneuroim.2015.04.006_bb0370","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa1114287","article-title":"DEFINE Study Investigators, Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis","volume":"367","author":"Gold","year":"2012","journal-title":"N Engl J Med."},{"key":"10.1016\/j.jneuroim.2015.04.006_bb0080","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.clim.2011.02.017","article-title":"Fumaric acid and its esters: an emerging treatment for multiple sclerosis with antioxidative mechanism of action","volume":"142","author":"Gold","year":"2012","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jneuroim.2015.04.006_bb0085","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1172\/JCI42273","article-title":"Nicotinic acid- and monomethyl fumarate-induced flushing involves GPR109A expressed by keratinocytes and COX-2-dependent prostanoid formation in mice","volume":"120","author":"Hanson","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2015.04.006_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2012.06.003","article-title":"Role of HCA(2) (GPR109A) in nicotinic acid and fumaric acid ester-induced effects on the skin","volume":"136","author":"Hanson","year":"2012","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jneuroim.2015.04.006_bb0095","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1046\/j.1365-2133.2003.05433.x","article-title":"Long-term safety aspects of systemic therapy with fumaric acid esters in severe psoriasis","volume":"149","author":"Hoefnagel","year":"2003","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jneuroim.2015.04.006_bb0100","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/S0140-6736(08)61619-0","article-title":"Efficacy and safety of oral fumarate in patients with relapsing\u2013remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study","volume":"372","author":"Kappos","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2015.04.006_bb0105","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1177\/1352458511421054","article-title":"Effect of BG-12 on contrast-enhanced lesions in patients with relapsing\u2013remitting multiple sclerosis: subgroup analyses from the phase 2b study","volume":"18","author":"Kappos","year":"2012","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2015.04.006_bb0110","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/sj.cdd.4401850","article-title":"TLR signaling","volume":"13","author":"Kawai","year":"2006","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.jneuroim.2015.04.006_bb0115","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/j.cellsig.2010.06.004","article-title":"Suppression of NF-kappaB signaling by KEAP1 regulation of IKKbeta activity through autophagic degradation and inhibition of phosphorylation","volume":"22","author":"Kim","year":"2010","journal-title":"Cell. Signal."},{"key":"10.1016\/j.jneuroim.2015.04.006_bb0125","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1096\/fj.04-1538fje","article-title":"An integrative biology approach for analysis of drug action in models of human vascular inflammation","volume":"18","author":"Kunkel","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.jneuroim.2015.04.006_bb0130","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1089\/adt.2004.2.431","article-title":"Rapid structure-activity and selectivity analysis of kinase inhibitors by BioMAP analysis in complex human primary cell-based models","volume":"2","author":"Kunkel","year":"2004","journal-title":"Assay Drug Dev. Technol."},{"key":"10.1016\/j.jneuroim.2015.04.006_bb0135","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S1074-5521(01)00049-7","article-title":"The anti-inflammatory natural product parthenolide from the medicinal herb Feverfew directly binds to and inhibits IkappaB kinase","volume":"8","author":"Kwok","year":"2001","journal-title":"Chem. Biol."},{"key":"10.1016\/j.jneuroim.2015.04.006_bb0140","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.molcel.2009.07.025","article-title":"KEAP1 E3 ligase-mediated downregulation of NF-kappaB signaling by targeting IKKbeta","volume":"36","author":"Lee","year":"2009","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jneuroim.2015.04.006_bb0145","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/sj.jid.5700686","article-title":"Dimethylfumarate induces immunosuppression via glutathione depletion and subsequent induction of heme oxygenase 1","volume":"127","author":"Lehmann","year":"2007","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jneuroim.2015.04.006_bb0150","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s11910-013-0394-8","article-title":"Dimethyl fumarate for treatment of multiple sclerosis: mechanism of action, effectiveness, and side effects","volume":"13","author":"Linker","year":"2013","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.jneuroim.2015.04.006_bb0155","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1586\/14737175.8.11.1683","article-title":"Fumarates for the treatment of multiple sclerosis: potential mechanisms of action and clinical studies","volume":"8","author":"Linker","year":"2008","journal-title":"Expert. Rev. Neurother."},{"key":"10.1016\/j.jneuroim.2015.04.006_bb0160","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/brain\/awq386","article-title":"Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway","volume":"134","author":"Linker","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2015.04.006_bb0165","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1365-2125.2004.02145.x","article-title":"Pharmacokinetics of oral fumarates in healthy subjects","volume":"58","author":"Litjens","year":"2004","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jneuroim.2015.04.006_bb0170","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/eji.200324174","article-title":"Monomethylfumarate affects polarization of monocyte-derived dendritic cells resulting in down-regulated Th1 lymphocyte responses","volume":"34","author":"Litjens","year":"2004","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jneuroim.2015.04.006_bb0175","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1471-2210-4-22","article-title":"In vitro pharmacokinetics of anti-psoriatic fumaric acid esters","volume":"4","author":"Litjens","year":"2004","journal-title":"BMC Pharmacol."},{"key":"10.1016\/j.jneuroim.2015.04.006_bb0180","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1365-2133.2005.07002.x","article-title":"Effects of monomethylfumarate on dendritic cell differentiation","volume":"154","author":"Litjens","year":"2006","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jneuroim.2015.04.006_bb0185","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1046\/j.0022-202x.2001.01576.x","article-title":"Dimethylfumarate inhibits tumor-necrosis-factor-induced CD62E expression in an NF-kappa B-dependent manner","volume":"117","author":"Loewe","year":"2001","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jneuroim.2015.04.006_bb0190","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.4049\/jimmunol.168.9.4781","article-title":"Dimethylfumarate inhibits TNF-induced nuclear entry of NF-kappa B\/p65 in human endothelial cells","volume":"168","author":"Loewe","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2015.04.006_bb0195","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.taap.2013.07.012","article-title":"Keap1 silencing boosts lipopolysaccharide-induced transcription of interleukin 6 via activation of nuclear factor kappaB in macrophages","volume":"272","author":"Lv","year":"2013","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.jneuroim.2015.04.006_bb0200","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00415-010-5777-z","article-title":"BG-12 reduces evolution of new enhancing lesions to T1-hypointense lesions in patients with multiple sclerosis","volume":"258","author":"MacManus","year":"2011","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2015.04.006_bb0205","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1111\/j.1365-2222.2004.02124.x","article-title":"Identification of anti-inflammatory drugs according to their capacity to suppress type-1 and type-2T cell profiles","volume":"34","author":"Moed","year":"2004","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.jneuroim.2015.04.006_bb0210","doi-asserted-by":"crossref","first-page":"60","DOI":"10.2174\/157015909787602788","article-title":"Fumaric Acid and its esters: an emerging treatment for multiple sclerosis","volume":"7","author":"Moharregh-Khiabani","year":"2009","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.jneuroim.2015.04.006_bb0215","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.molmed.2004.11.003","article-title":"Dimethylfumarate for psoriasis: more than a dietary curiosity","volume":"11","author":"Mrowietz","year":"2005","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.jneuroim.2015.04.006_bb0220","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1046\/j.1471-4159.2001.00157.x","article-title":"Preferential expression of antioxidant response element mediated gene expression in astrocytes","volume":"76","author":"Murphy","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jneuroim.2015.04.006_bb0225","first-page":"1927","article-title":"Effect of dietary inducer dimethylfumarate on glutathione in cultured human retinal pigment epithelial cells","volume":"40","author":"Nelson","year":"1999","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jneuroim.2015.04.006_bb0230","doi-asserted-by":"crossref","first-page":"13291","DOI":"10.1074\/jbc.R900010200","article-title":"The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress","volume":"284","author":"Nguyen","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jneuroim.2015.04.006_bb0235","doi-asserted-by":"crossref","first-page":"28017","DOI":"10.1074\/jbc.M112.383380","article-title":"Dimethyl fumarate inhibits dendritic cell maturation via nuclear factor kappaB (NF-kappaB) and extracellular signal-regulated kinase 1 and 2 (ERK1\/2) and mitogen stress-activated kinase 1 (MSK1) signaling","volume":"287","author":"Peng","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jneuroim.2015.04.006_bb0240","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1073\/pnas.95.6.3071","article-title":"Glutathione levels in antigen-presenting cells modulate Th1 versus Th2 response patterns","volume":"95","author":"Peterson","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2015.04.006_bb0245","doi-asserted-by":"crossref","first-page":"21096","DOI":"10.1074\/jbc.272.34.21096","article-title":"Novel inhibitors of cytokine-induced IkappaBalpha phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo","volume":"272","author":"Pierce","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jneuroim.2015.04.006_bb0250","doi-asserted-by":"crossref","first-page":"3944","DOI":"10.1038\/ncomms4944","article-title":"The beta-hydroxybutyrate receptor HCA2 activates a neuroprotective subset of macrophages","volume":"5","author":"Rahman","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jneuroim.2015.04.006_bb0255","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1600-065X.2011.01059.x","article-title":"Non-canonical NF-kappaB signaling activation and regulation: principles and perspectives","volume":"244","author":"Razani","year":"2011","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jneuroim.2015.04.006_bb0260","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.expneurol.2014.04.003","article-title":"Neuroprotective dimethyl fumarate synergizes with immunomodulatory interferon beta to provide enhanced axon protection in autoimmune neuroinflammation","volume":"257","author":"Reick","year":"2014","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.jneuroim.2015.04.006_bb0265","doi-asserted-by":"crossref","first-page":"133","DOI":"10.4103\/0378-6323.31908","article-title":"Use of fumaric acid esters in psoriasis","volume":"73","author":"Roll","year":"2007","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"key":"10.1016\/j.jneuroim.2015.04.006_bb0270","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.clindermatol.2008.07.001","article-title":"Fumaric acid esters","volume":"26","author":"Rostami Yazdi","year":"2008","journal-title":"Clin. Dermatol."},{"key":"10.1016\/j.jneuroim.2015.04.006_bb0275","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/jid.2008.197","article-title":"Detection of metabolites of fumaric acid esters in human urine: implications for their mode of action","volume":"129","author":"Rostami-Yazdi","year":"2009","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jneuroim.2015.04.006_bb0280","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00403-010-1061-4","article-title":"Pharmacokinetics of anti-psoriatic fumaric acid esters in psoriasis patients","volume":"302","author":"Rostami-Yazdi","year":"2010","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.jneuroim.2015.04.006_bb0285","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1124\/jpet.111.190132","article-title":"Fumarates promote cytoprotection of central nervous system cells against oxidative stress via the nuclear factor (erythroid-derived 2)-like 2 pathway","volume":"341","author":"Scannevin","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jneuroim.2015.04.006_bb0290","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1365-2249.2006.03094.x","article-title":"Fumaric acid esters are effective in chronic experimental autoimmune encephalomyelitis and suppress macrophage infiltration","volume":"145","author":"Schilling","year":"2006","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jneuroim.2015.04.006_bb0295","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.neuint.2010.01.006","article-title":"Fumaric acid diesters deprive cultured primary astrocytes rapidly of glutathione","volume":"57","author":"Schmidt","year":"2010","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.jneuroim.2015.04.006_bb0300","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.bmc.2006.09.053","article-title":"Reactivity of dimethyl fumarate and methylhydrogen fumarate towards glutathione and N-acetyl-l-cysteine-preparation of S-substituted thiosuccinic acid esters","volume":"15","author":"Schmidt","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jneuroim.2015.04.006_bb0305","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.clinthera.2013.08.009","article-title":"Tolerability and pharmacokinetics of delayed-release dimethyl fumarate administered with and without aspirin in healthy volunteers","volume":"35","author":"Sheikh","year":"2013","journal-title":"Clin. Ther."},{"key":"10.1016\/j.jneuroim.2015.04.006_bb0310","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/cr.2010.161","article-title":"A single NFkappaB system for both canonical and non-canonical signaling","volume":"21","author":"Shih","year":"2011","journal-title":"Cell Res."},{"key":"10.1016\/j.jneuroim.2015.04.006_bb0315","first-page":"7871","article-title":"Induction of glutathione transferases and NAD(P)H:quinone reductase by fumaric acid derivatives in rodent cells and tissues","volume":"50","author":"Spencer","year":"1990","journal-title":"Cancer Res."},{"key":"10.1016\/j.jneuroim.2015.04.006_bb0320","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1046\/j.1365-2133.2001.04220.x","article-title":"The antipsoriatic drug dimethylfumarate strongly suppresses chemokine production in human keratinocytes and peripheral blood mononuclear cells","volume":"144","author":"Stoof","year":"2001","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jneuroim.2015.04.006_bb0325","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1600-065X.2011.01088.x","article-title":"The noncanonical NF-kappaB pathway","volume":"246","author":"Sun","year":"2012","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jneuroim.2015.04.006_bb0330","doi-asserted-by":"crossref","first-page":"23573","DOI":"10.1074\/jbc.M200842200","article-title":"A small molecule ubiquitination inhibitor blocks NF-kappa B-dependent cytokine expression in cells and rats","volume":"277","author":"Swinney","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jneuroim.2015.04.006_bb0335","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.bbrc.2008.08.041","article-title":"The psoriasis drug monomethylfumarate is a potent nicotinic acid receptor agonist","volume":"375","author":"Tang","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jneuroim.2015.04.006_bb0340","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1006\/bbrc.1997.6570","article-title":"Dimethylfumarate is an inhibitor of cytokine-induced E-selectin, VCAM-1, and ICAM-1 expression in human endothelial cells","volume":"234","author":"Vandermeeren","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jneuroim.2015.04.006_bb0345","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1046\/j.1523-1747.2001.00211.x","article-title":"Dimethylfumarate is an inhibitor of cytokine-induced nuclear translocation of NF-kappa B1, but not RelA in normal human dermal fibroblast cells","volume":"116","author":"Vandermeeren","year":"2001","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jneuroim.2015.04.006_bb0350","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/bdd.364","article-title":"Presystemic metabolism and intestinal absorption of antipsoriatic fumaric acid esters","volume":"24","author":"Werdenberg","year":"2003","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.jneuroim.2015.04.006_bb0355","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1742-2094-7-30","article-title":"Dimethylfumarate inhibits microglial and astrocytic inflammation by suppressing the synthesis of nitric oxide, IL-1beta, TNF-alpha and IL-6 in an in-vitro model of brain inflammation","volume":"7","author":"Wilms","year":"2010","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2015.04.006_bb0360","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cellsig.2011.01.014","article-title":"Nuclear factor p65 interacts with Keap1 to repress the Nrf2-ARE pathway","volume":"23","author":"Yu","year":"2011","journal-title":"Cell. Signal."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572815000934?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572815000934?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:24:46Z","timestamp":1759047886000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572815000934"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":73,"alternative-id":["S0165572815000934"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2015.04.006","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DMF, but not other fumarates, inhibits NF-\u03baB activity in vitro in an Nrf2-independent manner","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2015.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}